首页 > 

646-ph

2025-01-21
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 12, 2024-- Takeda ( TSE:4502/NYSE:TAK ) will host an investor R&D Day today beginning at 8:30 a.m. JST in Tokyo. The meeting will focus on programs in the company’s late-stage pipeline, the transformative value they could deliver to patients, and the market opportunities they represent. “We are focused on advancing our innovative pipeline and accelerating late-stage programs to deliver sustainable revenue growth to 2030 and beyond, building upon the strong momentum of our Growth and Launch Products,” said Christophe Weber, Takeda chief executive officer. “The first three Phase 3 programs will read out in 2025, initiating a cadence of potential filings across multiple indications over the next several years.” Eight Regulatory Filings in FY2025 – FY2029 The late-stage pipeline includes oveporexton (TAK-861), zasocitinib (TAK-279), rusfertide (TAK-121), mezagitamab (TAK-079), fazirsiran (TAK-999) and elritercept (TAK-226). Combined these programs have potential peak revenue 1 of $10B - $20B. Data from three Phase 3 programs is expected to read out in 2025: oveporexton, a potential best-in-class and first-in-class investigational oral orexin receptor 2 agonist will report Phase 3 results in narcolepsy type 1; zasocitinib, an investigational next-generation, highly selective and potent oral allosteric tyrosine kinase 2 (TYK2) inhibitor will deliver Phase 3 results in psoriasis; and rusfertide, an investigational injectable hepcidin mimetic in development with partner Protagonist Therapeutics, will have Phase 3 results in polycythemia vera. Filings for these three indications are expected in fiscal years 2025 and 2026. Five additional indication filings for late-stage programs are on pace for fiscal years 2027 through 2029: zasocitinib in psoriatic arthritis; mezagitamab, an investigational anti-CD38 antibody providing rapid, selective and sustained depletion of disease-causing immune cells that could set a new standard for the treatment of immune thrombocytopenia (ITP) and immunoglobulin A neuropathy (IgAN); fazirsiran, an investigational RNA interference (RNAi) therapy that stops the production of misfolded abnormal protein Z-AAT directly addressing the pathology of alpha-1 antitrypsin deficiency liver disease (AATD-LD) and; elritercept, an investigational activin inhibitor designed to treat anemia associated with certain hematologic cancers, including myelodysplastic syndromes (MDS). Takeda recently signed an exclusive licensing agreement with Keros Therapeutics to further develop, manufacture and commercialize elritercept worldwide outside of mainland China, Hong Kong and Macau. The agreement is subject to customary closing conditions, including completion of antitrust reviews. “Takeda has established an exciting, late-stage pipeline of transformative therapies that we believe will deliver value to our company and, most importantly, to the patients we serve around the world,” said Andy Plump, president of R&D at Takeda. “As we continue scaling our capabilities and maximizing R&D investment to deliver the late-stage pipeline, we are also progressing an exciting early-stage pipeline, supporting a cutting-edge research organization, and focusing on creative business development across our therapeutic areas to sustain Takeda’s future and continue to meet significant unmet patient needs.” 2024 R&D Day Agenda The meeting includes the following presentations and speakers: A Global, Innovation-Driven Biopharmaceutical Company Christophe Weber, President & CEO R&D Strategy and Pipeline Highlights Andy Plump, President, Research and Development Neuroscience: Deep-Dive on Orexin Franchise Sarah Sheikh, Head of Neuroscience Therapeutic Area Unit and Head of Global Development Ramona Sequeira, President of Global Portfolio Division Gastrointestinal and Inflammation: Deep-Dive on Zasocitinib, Rusfertide, Mezagitamab, Fazirsiran Chinwe Ukomadu, Head of Gastrointestinal and Inflammation Therapeutic Area Unit Ramona Sequeira, President of Global Portfolio Division Oncology: Deep-Dive on Elritercept – Newly Announced Business Development Deal Teresa Bitetti, President Global Oncology Business Unit P.K. Morrow, Head of Oncology Therapeutic Area Unit Webcast Details A live webcast of the meeting begins at 8:30 a.m. JST December 13 (6:30 p.m. EST December 12). Presentations are available on the Investor Relations section of Takeda’s website where a video replay will be available following the meeting. About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com . Important Notice For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. Forward-Looking Statements This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov . Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results. Peak Sales and PTRS Estimates References in this press release to peak revenue potential ranges are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue potential ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. References in this press release to PTRS are to internal estimates of Takeda regarding the likelihood of obtaining regulatory approval for a particular product in a particular indication. These estimates reflect the subjective judgment of responsible Takeda personnel and have been approved by Takeda’s Portfolio Review Committee for use in internal planning. Medical Information This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Elritercept license agreement Elritercept is included for reference only. Takeda entered into an exclusive license agreement with Keros for global rights, in all territories outside of mainland China, Hong Kong and Macau, to Elritercept. The closing of the transaction is subject to receipt of regulatory approval(s), expected in the first calendar quarter of 2025. Takeda does not currently have rights to Elritercept. ___________________________ 1 References in this presentation to peak revenue potential are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. View source version on businesswire.com : https://www.businesswire.com/news/home/20241211148492/en/ CONTACT: Investor Relations Christopher O’Reilly Christopher.oreilly@takeda.com +81 (0) 90-6481-3412 Takeda Media Relations media_relations@takeda.com KEYWORD: MASSACHUSETTS UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC INDUSTRY KEYWORD: ONCOLOGY HEALTH NEUROLOGY CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Takeda Pharmaceutical Company Limited Copyright Business Wire 2024. PUB: 12/12/2024 05:30 PM/DISC: 12/12/2024 05:30 PM http://www.businesswire.com/news/home/20241211148492/enDoes Trump Jan 6. Pardon Plan Include the Seditionists?646-ph

NEW YORK and LONDON , Dec. 12, 2024 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC) (the "Company") today announced that it has priced an underwritten public offering of 1,200,000 shares of its 8.00% Series A Preferred Stock Due 2029 (the "Preferred Shares") at a public offering price of $25 per share, which will result in net proceeds to the Company of approximately $28.8 million after payment of underwriting discounts and estimated offering expenses payable by the Company. The Preferred Shares are rated 'BBB' by Egan-Jones Ratings Company, an independent rating agency. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 180,000 Preferred Shares pursuant to the same terms and conditions. The offering is expected to close on December 18, 2024 , subject to customary closing conditions. The Company intends to list the Preferred Shares on the New York Stock Exchange within 30 days of the original issue date under the symbol "PDPA." Lucid Capital Markets, LLC ("Lucid"), B. Riley Securities, Inc. and Kingswood Capital Partners, LLC are acting as joint book-running managers and InspereX LLC and Janney Montgomery Scott LLC are acting as lead managers for the offering. Investors should consider the Company's investment objectives, risks, charges and expenses carefully before investing. The preliminary prospectus, which has been filed with the Securities and Exchange Commission ("SEC"), contains this and other information about the Company and should be read carefully before investing. The information in the preliminary prospectus and this press release is not complete and may be changed. The preliminary prospectus and this press release are not offers to sell these securities and are not soliciting an offer to buy these securities in any state where such offer or sale is not permitted. A registration statement relating to these securities is on file with and has been declared effective by the SEC. Copies of the preliminary prospectus (and the final prospectus, when available) may be obtained by writing to Lucid Capital Markets, LLC, 570 Lexington Avenue, New York, New York 10022, by calling Lucid toll-free at 646-362-0256 or by sending an e-mail to Lucid at prospectus@lucid.com . Copies also may be obtained on the SEC's website at www.sec.gov . Egan-Jones Ratings Company is a nationally recognized statistical rating organization (NRSRO). A security rating is not a recommendation to buy, sell or hold securities, and any such rating may be subject to revision or withdrawal at any time by the applicable rating agency. About Pearl Diver Credit Company Inc. Pearl Diver Credit Company Inc. (NYSE: PDCC) is an externally managed, non-diversified, closed-end management investment company. Its primary investment objective is to maximize its portfolio's total return, with a secondary objective of generating high current income. The Company seeks to achieve these objectives by investing primarily in equity and junior debt tranches of CLOs collateralized by portfolios of sub-investment grade, senior secured floating-rate debt issued by a large number of distinct US companies across several industry sectors. The Company is externally managed by Pearl Diver Capital LLP. For more information, visit www.pearldivercreditcompany.com . Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the prospectus and the Company's other filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release. NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE Investor Contact: Info@Pearldivercap.com UK: +44 (0)20 3967 8032 US: +1 617 872 0945 View original content to download multimedia: https://www.prnewswire.com/news-releases/pearl-diver-credit-company-inc-prices-offering-of-series-a-preferred-stock-302330836.html SOURCE Pearl Diver Credit Company Inc.

To lure Juan Soto, Mets created a video of his statue outside Citi Field next to Tom Seaver's NEW YORK (AP) — The New York Mets wanted Juan Soto to know his future with them could be set in stone. When the free agent outfielder traveled to owner Steve Cohen’s house in Beverly Hills, California, for a presentation last month, the team showed a video that included an image of a future Soto statue outside Citi Field, next to the one erected of franchise great Tom Seaver. Soto put on a New York Mets jersey and cap for the first time Thursday after his record $765 million, 15-year contract was finalized and talked about what made the difference in his decision. Bill Belichick 'always wanted' to give college coaching a try. Now he will at North Carolina New North Carolina football coach Bill Belichick said he had long been interested in coaching in the college ranks. But it had never worked out until now, as he takes over the Tar Heels program. Belichick led the New England Patriots to six Super Bowl titles during a 24-year run there that ended last year. Belichick's five-year deal pays him $10 million in base and supplemental salary per year. It is guaranteed only for the first three years, including for buyout purposes. There is also up to $3.5 million in annual bonuses. Wander Franco's sex abuse trial has been postponed 5 months PUERTO PLATA, Dominican Republic (AP) — The trial against Tampa Bay Rays shortstop Wander Franco, who has been charged with sexually abusing a minor, sexual and commercial exploitation against a minor, and human trafficking, has been postponed until June 2, 2025. Dominican judge Yacaira Veras postponed the hearing Thursday at the request of prosecutors because of the absence of several key witnesses in the case. Franco’s lawyers asked the court to reconsider the postponement, arguing Franco must report to spring training in mid-February. The judge replied that Franco is obligated to continue with the trial schedule and his conditional release from detainment. LeBron James ruled out of Lakers' game at Minnesota on Friday with foot soreness LOS ANGELES (AP) — LeBron James has been ruled out of the Los Angeles Lakers’ game at Minnesota on Friday night due to soreness in his left foot. James will miss his second straight game when the Lakers return from a four-day break to face the Timberwolves. The top scorer in NBA history was away from the team this week with an excused absence attributed to “personal reasons,” coach JJ Redick said Wednesday. It’s unclear whether James will even make the quick round trip to Minnesota before the Lakers’ next game at home against Memphis on Sunday. Rape investigation that Swedish media say focused on Kylian Mbappé has been closed STOCKHOLM (AP) — Swedish prosecutors say they have dropped a rape investigation that was launched in connection with soccer star Kylian Mbappé’s visit to Stockholm in October. In a statement, lead investigator Marina Chirakova says there is not enough evidence to continue the investigation into the allegation at a hotel. Prosecutors never publicly named the suspect in the investigation but some Swedish media reported it was Mbappé. The Real Madrid striker visited Stockholm in October during a break in the Spanish league. At the time, Mbappé’s legal team dismissed those reports as false. Travis Hunter, the 2-way standout for Colorado, is the AP college football player of the year BOULDER, Colo. (AP) — Colorado two-way standout Travis Hunter is The Associated Press college football player of the year. Hunter received 26 of the 43 votes from a panel of AP Top 25 voters. Boise State tailback Ashton Jeanty finished second with 16 votes, and Arizona State running back Cameron Skattebo received one vote. A throwback player who rarely left the field, Hunter had 92 catches for 1,152 yards and 14 touchdowns as a receiver. He had four interceptions and 11 passes defensed as a shutdown corner. Hunter helped the the 20th-ranked Buffaloes to a 9-3 record and an appearance in the Alamo Bowl against BYU. 2034 World Cup visitors will live in 'a bubble' and not see real life, Saudi rights activist says LONDON (AP) — A Saudi human rights activist says soccer fans visiting Saudi Arabia for the 2034 World Cup will live in a “bubble” that doesn't reflect real life there. Lina al-Hathloul is a London-based activist whose sister was jailed in Saudi Arabia then banned from travel after campaigning to end a ban on women driving. When FIFA confirmed the kingdom as the 2034 tournament host on Wednesday its president Gianni Infantino acknowledged “the world will be watching” for positive social change. Al-Hathloul says western people “will be very safe” at the World Cup but "will see a bubble of what Saudi Arabia is.” Team claims NASCAR rescinded approval to buy new charter unless federal antitrust suit is dropped CHARLOTTE, N.C. (AP) — A new court filing says NASCAR rejected Front Row Motorsports’ agreement to purchase a charter from Stewart-Haas Racing unless the team and 23XI Racing dropped their federal antitrust lawsuit against the stock car series. Front Row and 23XI rejected NASCAR's new revenue sharing agreement and have gone to court. NASCAR now says it will move forward in 2025 with 32 chartered teams and eight open spots, with offers on charters for Front Row and 23XI rescinded and the SHR charters in limbo. Indian teen Gukesh Dommaraju becomes the youngest chess world champion after beating Chinese rival NEW DELHI (AP) — Indian teenager Gukesh Dommaraju has become the youngest chess world champion after beating the defending champion Ding Liren of China. Dommaraju, 18, secured 7.5 points against 6.5 of his Chinese rival in Thursday's game which was played in Singapore. He has surpassed the achievement of Russia’s Garry Kasparov who won the title at the age of 22. Dommaraju is now also the second Indian to win the title after five-time world chess champion Viswanathan Anand. The Indian teen prodigy has long been considered a rising star in the chess world after he became a chess grandmaster at 12. He had entered the match as the youngest-ever challenger to the world crown after winning the Candidates tournament earlier this year. Hojlund scores twice for Man United to beat Viktoria Plzen 2-1 in Europa League, Tottenham held 1-1 Rasmus Hojlund scored twice after coming off the bench and Manchester United rallied to beat Viktoria Plzen 2-1 in the Europa League. The Denmark striker netted in the 88th minute after collecting Bruno Fernandes’ pass off a free kick to seal the victory. Hojlund came on in the 56th and scored an equalizer six minutes later. Totenham was held 1-1 at Rangers and Lazio tops the standings after a 3-1 win at Ajax. In the Conference League a youthful Chelsea lineup made the most of a long trip to Kazakhstan by beating Astana 3-1 to stay perfect in the third-tier competition.Donald Trump, eager to turn his inauguration into a global event, is personally extending invitations to some foreign leaders, including heads of state that have clashed with the United States in the recent past. Already, Trump has asked Chinese President Xi Jinping to attend his swearing in, his transition team confirmed Thursday, an exceptionally rare offer extended to the communist leader of one of America’s chief geopolitical rivals. “This is an example of President Trump creating an open dialogue with leaders of countries that are not just allies but our adversaries and our competitors, too,” Trump spokeswoman Karoline Leavitt said during an appearance Thursday on Fox News. A delegation of senior Chinese officials is expected to attend in place of Xi, according to two sources familiar with the matter. El Salvador’s President Nayib Bukele, Italian Prime Minister Giorgia Meloni and Argentinean President Javier Milei have also been invited by Trump or his team, sources confirmed to CNN. All three are close allies of Trump who have also shaken the nerves of the US and its allies at times for their embrace of strongman tactics and their far-right politics. The offers to attend his Washington fêting have been mostly informal, a person with knowledge of the conversations told CNN, and have sometimes come in passing during discussions over the phone about other matters. The person also said that some invitations have gone through back channels, not directly leader-to-leader. Trump has also dictated written invitations as well, a source familiar with the matter said, and had his team send them to foreign leaders. Trump’s transition team did not respond to questions about what other leaders he invited. On Thursday, the president-elect suggested he may invite other foreign leaders people told him may be “a little risky.” “We like to take little chances,” Trump said. “But that’s not a bad chance.” A new diplomatic era for America It is up to the president-elect and his team to determine which guests attend his inauguration, including any world leaders they may invite, one source familiar with the process told CNN. Generally, the bipartisan Joint Congressional Committee on Inaugural Ceremonies and the State Department will reach out to diplomats to attend. The JCCIC has already begun sending invitations to every country’s chief of mission, as part of its typical protocol. It’s rare, however, for heads of state to make international visits to Washington for an inauguration, and it’s up to the discretion of the incoming president to make such asks, the source said. The outreach beyond America’s closest Western allies signals a new diplomatic era for the United States. In an interview with Time conducted in late November and published Thursday, Trump touched on his existing relationships with authoritarian leaders like North Korea’s Kim Jong Un and Russia’s Vladimir Putin – though he declined to say if he has spoken with Putin since winning in November. “I get along with Russia,” Trump told the news magazine, which also named him “Person of the Year” on Thursday. “I get along with a lot of people that people would think I wouldn’t get along with.” The invites to world leaders also speak to Trump’s early interest in reengaging with his foreign peers four years after he left Washington, DC, and the world stage defeated and diminished. In the weeks since completing his political comeback, Trump has spoken with leaders from around the globe and hosted several at his Palm Beach, Florida, club. On social media, he has already engaged in global affairs, threatening Mexico and Canada with 25% tariffs and calling for a ceasefire between Ukraine and Russia. Trump told Time magazine he opposed a new US policy allowing Ukraine to fire long-range missiles into Russia. Trump also has an overseas trip under his belt: a visit to the reopening of the Notre Dame Cathedral in Paris, an appearance that came at the invitation of French President Emmanuel Macron. Trump returned enamored by the pageantry – and also the high-profile attendance. While there, he also met with Ukrainian President Volodymyr Zelensky, the United Kingdom’s Prince William and Meloni. “It was something really beautiful,” Trump said Thursday. “And a lot of world leaders, there were about 80 world leaders, different countries, and they were all coming together.” Trump’s desire for a ‘global stage’ in DC Now, he is looking to turn his inauguration into a similar must-attend affair. “Trump is very eager to have world leaders at the inauguration,” one Trump adviser told CNN. “He wants a global stage.” However, the freewheeling nature of Trump’s invites has made it difficult for even his closest aides to keep track of everyone who has and has not received an invitation to his second inauguration. It also poses additional security challenges for the United States Secret Service, which is mandated to protect all heads of state when they are on US soil. The US Capital Police is already tasked with protecting that day an incoming president who survived two assassination attempts over the summer, as well as the leaders of Congress, the Supreme Court, outgoing President Joe Biden and whichever past presidents attend. Xi is not expected, but it is not entirely clear yet which leaders intend to take Trump up on his offer. Bukele’s office confirmed receiving an invitation on behalf of Trump, however, it is unclear if the Salvadorian president plans on attending. In a recent interview with NBC’s “Meet the Press,” Trump shared that he and Xi had communicated regularly since his election, even as he continues to threaten to launch a broad trade war with China after taking office. Asked earlier Thursday while on the floor of the New York Stock Exchange whether Xi had accepted his invitation, Trump said, “I don’t want to say,” and added that the two leaders had a “very good relationship.” “I’ve invited a lot of great people, and they’ve all accepted,” Trump said. “Everybody I’ve invited has accepted.” CNN’s David Culver and Kayla Tausche contributed to this report.

Couple in mortgage hell, hit hard by XmasThe Edmonton Oilers have been on a run of some quality hockey lately, but in a few critical matchups against some playoff opponents, their lack of toughness showed to be a need. Oilers insider Bob Stauffer has been hinting for a while now that Edmonton may add a bottom six forward with energy. Now, analyst Kurt Leavins is seconding that belief in his latest article in the Edmonton Journal , saying that Stan Bowman will be acquiring some grit via trade at the deadline this year. - Kurt Leavins, Edmonton Journal The Oilers bottom six got pushed around by some playoff opponents in Florida and Los Angeles, showing some weaknesses in the bottom six that other teams can exploit in a 7 game series. The skill of the Oilers superstars w can still lead them to a win, but every line needs to be at their best for a Stanley Cup team - and specifically the fourth line currently doesn't have an identity. Oilers Will Likely Target Physical Bottom Six Forward in Trade The Edmonton Oilers currently rank last place in hits, and aren't getting much from any of their fourth line players. Jeff Skinner seems to be on the way out, Derek Ryan is pushing his limits at 37 years old, and Corey Perry can't drive a line on his own. Evander Kane's return from injury may be a wild card for the team, but he alone may not be able to give the Oilers a physical edge. While the team may be targeting a defenceman and potentially a third goaltender, adding another bottom six forward may need to be a priority for Oilers GM Stan Bowman. In the grind through 4 best of seven series, playoff hockey becomes a battle of attrition. Being able to handle the physical side of the game is essential to compete in the playoffs, and the Oilers sorely need more of it. This article first appeared on Oilers Daily and was syndicated with permission.

DEAR RUSTY: I turned 64 in July and my wife turned 62 in August. My wife has not worked for approximately 15 years but does qualify for Social Security on her prior work record. My wife is having some physical issues and would like to not return to work. Since she is eligible to collect Social Security, that would be an option to provide additional income, so she doesn’t have to work. My question is how would it affect her future SS spousal benefits based on my record if she begins collecting her own benefit now? I plan to work until at least my full retirement age (67), and maybe longer, but plan to start collecting SS at 67 even I continue working. — Working Husband DEAR WORKING: If your wife has the required 40 SS quarter credits, she is eligible to collect reduced retirement benefits at 62 (for that needed extra income), but her age 62 benefit will be about 70% of what it would be if she waited until her SS full retirement age (FRA) to claim. That reduction would, in turn, carry over to her spousal benefit when you eventually claim your SS benefit. Here’s why: Your wife’s spousal amount when you claim will be a combination of her own SS retirement benefit, plus an auxiliary amount (a “spousal boost”) that she is entitled to as your spouse. At age 62, her own benefit will be cut by 30% and she can collect that reduced amount until you claim, at which point her spousal boost will be added to make her benefit equal her spousal entitlement. So, her total benefit as your spouse (when you claim) will consist of her reduced age-62 amount, plus an additional amount as your spouse. If you claim at 67, your wife will be about two years short of her own FRA, which means that her spousal boost amount will also be reduced for early claiming. That reduced spousal boost will be added to her already reduced (age 62) SS retirement benefit, which will make her total benefit less than 50% of your FRA benefit amount. So, your wife claiming her own reduced SS retirement benefit at 62 also means her spousal benefit amount will be affected, and taking her spousal boost before her FRA means that the boost amount will also be reduced for early claiming. The only way your wife can get the full 50% of your FRA entitlement is to wait until she reaches her own FRA (67) to claim Social Security benefits. Having said all of that, if your wife’s physical issues suggest that she claims her benefits early and she is comfortable with the smaller benefit she will get, then that may be the right choice. For reference, the reduction to your wife’s spousal boost amount (if you claim at your FRA) will be about 17%, and that reduced spousal boost will be added to her reduced age 62 SS retirement amount. The end benefit for your wife (if you claim at age 67) will likely be about 42% of your FRA entitlement (instead of 50%). FYI, you can further delay your own SS retirement benefit (up to age 70) for a higher benefit yourself, but that would also mean your wife would need to wait longer to get her spousal boost. You could also wait to claim your SS until your wife reaches age 67 (her FRA), which would give you a higher personal amount and also ensure your wife gets her maximum spousal boost (but her total will still be less than 50% of yours because she claimed her own SS retirement benefit at 62). When to claim Social Security depends on financial need and life expectancy. If a long life expectancy is anticipated, waiting longer to claim is often the best move. But financial need always trumps waiting longer. (Russell Gloor is the national Social Security advisor at the AMAC Foundation, the non-profit arm of the Association of Mature American Citizens.)

Judiciary giving criminals a free pass

Conor McGregor must pay $250K to woman who says he raped her, civil jury rules

Provides 2000 A15 Hydro Bitcoin mining machines in initial order Continues global expansion with addition of new customer SINGAPORE , Dec. 12, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that Canaan Creative Global Pte. Ltd. ("CCG"), a wholly owned Singapore subsidiary of the Company, has entered into a purchase agreement with AGM Group Holdings Inc. ("AGMH"), an integrated technology company specializing in fintech software services and production of high-performance hardware and computing equipment, for its Avalon A15 HydU 370T ("A15 Hydro") mining machines. As part of the agreement, Canaan will initially provide 2,000 Bitcoin mining machines to AGMH. The Company has also agreed to provide its customer with an option to acquire approximately 30,000 additional BTC mining units, potentially providing AGMH with a combined power capacity not exceeding 300 megawatts. The Avalon Miner A15 Hydro enhances the miner's performance and lifespan while reducing energy consumption and noise pollution, aligning with Canaan's ESG (Environmental, Social, and Governance) strategy. About Canaan Inc. Established in 2013, Canaan Inc. (NASDAQ: CAN), is a technology company focusing on ASIC high-performance computing chip design, chip research and development, computing equipment production, and software services. Canaan has extensive experience in chip design and streamlined production in the ASIC field. In 2013, Canaan's founding team shipped to its customers the world's first batch of mining machines incorporating ASIC technology in bitcoin 's history under the brand name Avalon. In 2019, Canaan completed its initial public offering on the Nasdaq Global Market. To learn more about Canaan, please visit https://www.canaan.io/ . Safe Harbor Statement This announcement contains forward−looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward−looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as Canaan Inc.'s strategic and operational plans, contain forward−looking statements. Canaan Inc. may also make written or oral forward−looking statements in its periodic reports to the U.S. Securities and Exchange Commission ("SEC") on Forms 20−F and 6−K, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Canaan Inc.'s beliefs and expectations, are forward−looking statements. Forward−looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward−looking statement, including but not limited to the following: the Company's goals and strategies; the Company's future business development, financial condition and results of operations; the expected growth of the bitcoin industry and the price of bitcoin ; the Company's expectations regarding demand for and market acceptance of its products, especially its bitcoin mining machines; the Company's expectations regarding maintaining and strengthening its relationships with production partners and customers; the Company's investment plans and strategies, fluctuations in the Company's quarterly operating results; competition in its industry; and relevant government policies and regulations relating to the Company and cryptocurrency . Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Canaan Inc. does not undertake any obligation to update any forward−looking statement, except as required under applicable law. Investor Relations Contacts Canaan Inc. Xi Zhang Email: IR@canaan-creative.com ICR, LLC. Robin Yang Tel: +1 (347) 396-3281 Email: canaan.ir@icrinc.com View original content: https://www.prnewswire.com/news-releases/canaan-inc-signs-agreement-with-agm-group-holdings-inc-302330362.html SOURCE Canaan Inc.

Georgia quarterback Carson Beck announced Saturday that he will forgo his final year of eligibility and enter the 2025 NFL Draft. Beck, 22, led the Southeastern Conference with 28 touchdown passes and finished third in the SEC with 3,485 passing yards. He also led the conference in interceptions, however. Beck will be a spectator for the Bulldogs in the College Football Playoff after undergoing surgery Monday to repair the ulnar collateral ligament in his right (throwing) elbow. Gunner Stockton is in line to guide No. 2 seed Georgia into the CFP, starting with the Bulldogs' quarterfinal game against No. 7 seed Notre Dame at the Sugar Bowl on Wednesday in New Orleans. "There's unfinished business still this season and I'll be here to support however I can, finish strong!" Beck said in a statement posted on social media. Beck, a fifth-year senior, finished with a 24-3 record in his career with Georgia. "The past five years at the University of Georgia have been nothing short of a dream come true and I will forever cherish the memories that have been made. Thank you Dawg Nation for the time I've been here and to those who've supported and believed in me, thank you," Beck wrote on social media. "It's been an incredible journey and all these moments have ultimately led me to take the next step in my football career. With that being said, I will be declaring for the 2025 NFL Draft. Go Dawgs!" Beck, the Bulldogs' starter all year, was replaced in the second half of the SEC title game with the injury. Stockton helped to guide the Bulldogs to a 22-19 overtime win over Texas and clinch a first-round bye in the first 12-team playoff. --Field Level Media

Sam Darnold completed 33 of 43 passes for a career-best 377 yards to go with three touchdowns and one interception, and the Minnesota Vikings escaped with a 27-25 win over the Green Bay Packers on Sunday afternoon in Minneapolis. Justin Jefferson had eight catches for 92 yards for Minnesota (14-2), which won its ninth game in a row. Jalen Nailor, Jordan Addison and Cam Akers had one touchdown reception apiece for the Vikings. Jordan Love completed 19 of 30 passes for 185 yards and one touchdown for Green Bay (11-5). Josh Jacobs and Emanuel Wilson each rushed for a touchdown and Malik Heath had a touchdown catch for the Packers, who lost to the Vikings for the second time this season. Minnesota's nine-game winning streak matches its third longest in franchise history. The Vikings are enjoying their longest stretch of success since 1975, when they won 10 straight. Green Bay rallied with back-to-back touchdowns in the fourth quarter to pull within two. Wilson scored on a 5-yard run to cut the Packers' deficit to 27-18 with 6:12 to go. Love brought Green Bay within 27-25 with 2:18 to play. He fired a 3-yard touchdown pass to Heath, who scored on a quick slant. The Vikings got the ball on the following kickoff and never gave it back to Green Bay. Darnold secured the win when he lobbed a pass to Akers for a first down to set up the victory formation. The Packers opened the scoring late in the first quarter with a 22-yard field goal by Brandon McManus. Minnesota responded to grab a 13-3 lead at the half. Darnold found Nailor for a 31-yard touchdown with 11:52 remaining in the first half. Nailor was wide open and made a basket catch near the back of the end zone. Reichard rounded out the first-half scoring with field goals from 25 yards and 50 yards. The Vikings increased their lead to 20-3 on the opening drive of the second half. Addison made a diving grab for an 18-yard touchdown. Green Bay pulled within 20-10 with 5:07 left in the third quarter. Jacobs scored on a 2-yard run. Darnold's third touchdown pass, this time to Akers, made it 27-10 in favor of the Vikings with 51 seconds remaining in the third quarter. --Field Level Media

EVANSVILLE, Ind. (AP) — Cameron Haffner scored 13 points as Evansville beat Missouri State 57-40 on Sunday to snap a five-game losing streak. Haffner went 5 of 12 from the field (3 for 7 from 3-point range) for the Purple Aces (4-9, 1-1 Missouri Valley Conference). Joshua Hughes added 11 points, nine rebounds and four steals. Tayshawn Comer scored 11. Dez White finished with 12 points, four assists and six steals for the Bears (7-6, 0-2). Missouri State also got 10 points, 12 rebounds and two steals from Michael Osei-Bonsu. Zaxton King had eight points. Evansville carried a slim three-point lead into halftime, as Haffner led the way with seven points. Evansville took the lead for what would be the final time on Haffner's 3-pointer with 18:44 remaining in the second half. His team would outscore Missouri State by 14 points in the second half. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

Previous: 5jili
Next: 646 lodi